Back to search

National and Kapodistrian University of Athens

Φαρμακευτική έναντι ηλεκτρικής ανάταξης σε ασθενείς με κολπική μαρμαρυγή στο τμήμα επειγόντων περιστατικών: συσχέτιση με βιοχημικούς δείκτες και πρόγνωση ασθενών

Abstract

dc:description

Background:Atrial fibrillation (AF) is a common arrhythmia in the emergency department (ED). We investigated the role of N-terminal pro b-type natriuretic peptide (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF recurrence or persistence on the 8th (D8) and 30th (D30) day post-cardioversion. Methods: This prospective, observational study evaluated patients with recent-onset AF, managed by either pharmacological (PC) or electrical cardioversion (EC) in the ED. Patients were treated either immediately or electively after 3 weeks of anticoagulation. NT-proBNP assessments were performed prior to cardioversion. Results: Of the 148 patients enrolled, 56% had paroxysmal AF, 85% underwent immediate cardioversion and 72% received EC. Successful cardioversion to sinus rhythm (SR) was achieved in 85% of patients. Patients with successful cardioversion and those who remained free from AF on D8 had lower NT-proBNP levels compared to patients with failed cardioversion or with AF recurrence or persistence on D8 [day of cardioversion, D0: SR vs. non-SR, 387 (127–1095) pg/mL vs. 1262 (595–2295), p = 0.004; D8: SR vs. non-SR, 370 (127–1095) vs. 1366 (718–2295), p = 0.002]. In multivariate analysis, higher logNT-proBNP was associated with higher risk of cardioversion failure [OR (95% CI): 4.80 (1.58–14.55), p = 0.006] and AF recurrence or persistence on D8 [OR (95% CI): 3.65 (1.06–12.59), p = 0.041]. ROC analysis confirmed the predictive ability of NT-proBNP for both outcomes (D0: AUC 0.735, p < 0.001; D8: AUC 0.761, p < 0.001). A cut-off value of NT-proBNP > 580 pg/mL was able to predict failure of AF conversion and occurrence of recurrent/persistent AF at D8. Conclusions: NT-proBNP is a promising biomarker for identifying patients presenting to the ED with recentonset AF who run a greater risk of cardioversion failure and post-discharge AF recurrence/persistence in the immediate and short term

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Diakantonis, Antonios
  • Διακαντώνης, Αντώνιος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61614

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Diakantonis, Antonios; Διακαντώνης, Αντώνιος. Φαρμακευτική έναντι ηλεκτρικής ανάταξης σε ασθενείς με κολπική μαρμαρυγή στο τμήμα επειγόντων περιστατικών: συσχέτιση με βιοχημικούς δείκτες και πρόγνωση ασθενών. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/61614